Prognostic Significance of Epidermal Growth Factor Receptor Expression in Distant Metastatic Melanoma from Primary Cutaneous Melanoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background Epidermal growth factor receptor (EGFR) is overexpressed in many cancers. However, EGFR expression in melanoma and its role are conflicting. Objective This study aimed to evaluate EGFR expression in distant metastatic melanoma and analyze its relationship with histologic and clinical characteristics and survival. Methods Diagnostic tissues from 55 cases of distant metastatic melanoma was evaluated by immunohistochemistry for EGFR expression. Clinicopathologic features and survival outcomes were analyzed according to EGFR expression. Results The positive EGFR expression in distant metastatic melanoma was significantly correlated with the absence of ulceration. The EGFR expression in distant metastatic melanoma was significantly associated with poor survival, under the conditions of male sex and primary cutaneous melanoma without ulceration or Breslow thickness ≤4.0 mm. This study bears limitations of a retrospective study in a single institution. Conclusion EGFR immunostaining had predictive values for survival outcome. The EGFR expression in distant metastatic melanoma in male, no ulcer, or Breslow thickness ≤4.0 mm appeared to be involved in disease progression.
Abstract
Background Epidermal growth factor receptor (EGFR) is overexpressed in many cancers. However, EGFR expression in melanoma and its role are conflicting. Objective This study aimed to evaluate EGFR expression in distant metastatic melanoma and analyze its relationship with histologic and clinical characteristics and survival. Methods Diagnostic tissues from 55 cases of distant metastatic melanoma was evaluated by immunohistochemistry for EGFR expression. Clinicopathologic features and survival outcomes were analyzed according to EGFR expression. Results The positive EGFR expression in distant metastatic melanoma was significantly correlated with the absence of ulceration. The EGFR expression in distant metastatic melanoma was significantly associated with poor survival, under the conditions of male sex and primary cutaneous melanoma without ulceration or Breslow thickness ≤4.0 mm. This study bears limitations of a retrospective study in a single institution. Conclusion EGFR immunostaining had predictive values for survival outcome. The EGFR expression in distant metastatic melanoma in male, no ulcer, or Breslow thickness ≤4.0 mm appeared to be involved in disease progression.
참고문헌 (25)
- Hynes NE, "ErbB receptors and signaling pathways in cancer", Curr Opin Cell Biol, 21, pp.177~184 (2009)
- Seshacharyulu P, "Targeting the EGFR signaling pathway in cancer therapy", Expert Opin Ther Targets, 16, pp.15~31 (2012)
- Di Domenico M, "Signal transduction growth factors : the effective governance of transcription and cellular adhesion in cancer invasion", Oncotarget, 8, pp.36869~36884 (2017)
- Avruch J, "Ras activation of the Raf kinase : tyrosine kinase recruitment of the MAP kinase cascade", Recent Prog Horm Res, 56, pp.127~155 (2001)
- Yamaguchi H, "Pathological roles of invadopodia in cancer invasion and metastasis", Eur J Cell Biol, 91, pp.902~907 (2012)
- Mader CC, "An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion", Cancer Res, 71, pp.1730~1741 (2011)
- Feigin ME, "ErbB receptors and cell polarity : new pathways and paradigms for understanding cell migration and invasion", Exp Cell Res, 315, pp.707~716 (2009)
- Nicholson RI, "EGFR and cancer prognosis", Eur J Cancer, 37(Suppl 4), pp.S9~S15 (2001)
- Motoyama AB, "The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides", Cancer Res, 62, pp.3151~3158 (2002)
- Liu X, "MicroRNA-370 inhibits the growth and metastasis of lung cancer by down-regulating epidermal growth factor receptor expression", Oncotarget, 8, pp.88139~88151 (2017)
- Rákosy Z, "EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis", Int J Cancer, 121, pp.1729~1737 (2007)
- Czyz M, "Fibroblast growth factor receptor signaling in skin cancers", Cells, 8, pp.540~ (2019)
- Yamada T, "Evaluation of epidermal growth factor receptor in squamous cell carcinoma of the oral cavity", Oral Surg Oral Med Oral Pathol, 73, pp.67~70 (1992)
- Ellis DL, "Increased epidermal growth factor receptors in melanocytic lesions", J Am Acad Dermatol, 27, pp.539~546 (1992)
- Kovacs E, "A structural perspective on the regulation of the epidermal growth factor receptor", Annu Rev Biochem, 84, pp.739~764 (2015)
- De Wit PE, "Increasing epidermal growth factor receptor expression in human melanocytic tumor progression", J Invest Dermatol, 99, pp.168~173 (1992)
- Real FX, "Expression of epidermal growth factor receptor in human cultured cells and tissues : relationship to cell lineage and stage of differentiation", Cancer Res, 46, pp.4726~4731 (1986)
- Katunarić M, "EGFR and cyclin D1 in nodular melanoma : correlation with pathohistological parameters and overall survival", Melanoma Res, 24, pp.584~591 (2014)
- Ascierto PA, "Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial", Lancet Oncol, 17, pp.1248~1260 (2016)
- Testori A, "Diagnosis and treatment of in-transit melanoma metastases", Eur J Surg Oncol, 43, pp.544~560 (2017)
- Lim Y, "Is the survival rate for acral melanoma actually worse than other cutaneous melanomas", J Dermatol, 47, pp.251~256 (2020)
- Giard DJ, "In vitro cultivation of human tumors : establishment of cell lines derived from a series of solid tumors", J Natl Cancer Inst, 51, pp.1417~1423 (1973)
- Boone B, "EGFR in melanoma : clinical significance and potential therapeutic target", J Cutan Pathol, 38, pp.492~502 (2011)
- Keung EZ, "The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care", Expert Rev Anticancer Ther, 18, pp.775~784 (2018)
- Balch CM, "Final version of 2009 AJCC melanoma staging and classification", J Clin Oncol, 27, pp.6199~6206 (2009)